Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women

Clinical Pharmacokinetics

Volumn 47, Issue 2, 2008, Pages 103-109

  Lobo, Evelyn D ^a   Loghin, Corina ^a   Knadler, Mary Pat ^a   Quinlan, Tonya ^a   Zhang, Lu ^a   Chappell, Jill ^a   Lucas, Richard ^a   Bergstrom, Richard F ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Breast feeding; Breast milk; Duloxetine, adverse reactions; Duloxetine, pharmacokinetics

Indexed keywords

DULOXETINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BREAST FEEDING; BREAST MILK; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EXPOSURE; DRUG SAFETY; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MATERNAL PLASMA; MORNING DOSAGE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PUERPERIUM; RATING SCALE; RISK ASSESSMENT; SIDE EFFECT; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; VITAL SIGN;

ADMINISTRATION, ORAL; ADULT; ALGORITHMS; AREA UNDER CURVE; BLOOD PRESSURE; BODY MASS INDEX; CAPSULES; CHROMATOGRAPHY, LIQUID; DIZZINESS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; HEADACHE; HEART RATE; HUMANS; LACTATION; MILK, HUMAN; NAUSEA; POSTPARTUM PERIOD; SEROTONIN UPTAKE INHIBITORS; TANDEM MASS SPECTROMETRY; THIOPHENES;

EID: 38149138047     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200847020-00003     Document Type: Article

References (28)

1. Detke MJ, Wiltse CG, Mallinckrodt CH, et al. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol 2004; 14 (6): 457-70
2. Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005; 6 (5): 346-56
3. van Kerrebroeck P, Abrams P, Lange R, et al. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 2004; 111 (3): 249-57
4. Rynn M, Russell J, Erickson J, et al. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depress Anxiety. Epub 2007 Feb 20
5. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62 (6): 617-27
6. Miller YD, Brown WJ, Russell A, et al. Urinary incontinence across the lifespan. Neurourol Urodyn 2003; 22 (6): 550-7
7. Meyer S, Schreyer A, De Grandi P, et al. The effects of birth on urinary continence mechanisms and other pelvic-floor characteristics. Obstet Gynecol 1998; 92 (4 Pt 1): 613-8
8. Ross LE, McLean LM. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 2006; 67 (8): 1285-98
9. 14C]LY248686) administered as the hydrochloride salt. Indianapolis (IN): Eli Lilly and Company, 1998. (Data on file)
10. Allen JC, Keller RP, Archer P, et al. Studies in human lactation: milk composition and daily secretion rates of macronutrients in the first year of lactation. Am J Clin Nutr 1991; 54 (1): 69-80
11. Lantz RJ, Gillespie TA, Rash TJ, et al. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Metab Dispos 2003; 31 (9): 1142-50
12. Skinner MH, Kuan HY, Pan A, et al. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers. Clin Pharmacol Ther 2003; 73 (3): 170-7
13. Letner C, editor. Geigy scientific tables. Volume 1. West Caldwell (NJ): Ciga-Geigy Corporation, 1981: 213-6
14. Bennett PN. Drugs and human lactation. Amsterdam: Elsevier Science BV, 1996
15. WHO Child and Adolescent Health and Development. Community-based strategies for breastfeeding promotion and support in developing countries [online]. Available from URL: http://www.who.int/child-adolescent-health/ publications/ NUTRITION/ISBN_92_4_159121_8.htm [Accessed 2007 Nov 22]
16. Sharma A, Goldberg MJ, Cerimele BJ. Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor. J Clin Pharmacol 2000; 40 (2): 161-7
17. Gahimer J, Wernicke J, Yalcin I, et al. A retrospective pooled analysis of duloxetine safety in 23,983 subjects. Curr Med Res Opin 2007; 23 (1): 175-84
18. Poppas A, Shroff SG, Korcarz CE, et al. Serial assessment of the cardiovascular system in normal pregnancy: role of arterial compliance and pulsatile arterial load. Circulation 1997; 95 (10): 2407-15
19. Dodd S, Buist A, Norman TR. Antidepressants and breast-feeding: a review of the literature. Paediatr Drugs 2000; 2 (3): 183-92
20. Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002; 53 (1): 17-22
21. Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004; 161 (6): 1066-78
22. Hallberg P, Sjoblom V. The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol 2005; 25 (1): 59-73
23. Hendrick V, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001; 179: 163-6
24. Schmidt K, Olesen OV, Jensen PN. Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 2000; 47 (2): 164-5
25. Stowe ZN, Hostetter AL, Owens MJ, et al. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J Clin Psychiatry 2003; 64 (1): 73-80
26. Berle JO, Steen VM, Aamo TO, et al. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry 2004; 65 (9): 1228-34
27. Hendrick V, Altshuler L, Wertheimer A, et al. Venlafaxine and breast-feeding. Am J Psychiatry 2001; 158 (12): 2089-90
28. Ilett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 1998; 45 (5): 459-62